The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8182820 B1

PDF
Full Text
Expired
Date of Patent:
May. 22, 2012

Filed:

Mar. 19, 2009
Applicants:

Janet K. Yamamoto, Gainesville, FL (US);

Jennifer White Janelle, Gainesville, FL (US);

Barbara Aurea Torres, Gainesville, FL (US);

Maki Arai, Gainesville, FL (US);

Taishi Tanabe, Gainesville, FL (US);

Ruiyu Pu, Gainesville, FL (US);

Inventors:

Janet K. Yamamoto, Gainesville, FL (US);

Jennifer White Janelle, Gainesville, FL (US);

Barbara Aurea Torres, Gainesville, FL (US);

Maki Arai, Gainesville, FL (US);

Taishi Tanabe, Gainesville, FL (US);

Ruiyu Pu, Gainesville, FL (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01);
U.S. Cl.
CPC ...
Abstract

The subject invention pertains to materials and methods for detecting, preventing and treating retroviral infections in humans and other animals susceptible to infection by retrovirus. It has been discovered that FIV can be transmitted from cats to humans and that the FIV can infect human cells in vivo and that antibodies generated by the infected person cross-react with HIV antigens. Thus, the methods and compositions of the subject invention can be used to detect, prevent and treat FIV infection in humans and other non-feline animals that are susceptible to FIV infection. The methods and compositions of the invention can also be used to prevent and treat infection by HIV in humans.


Find Patent Forward Citations

Yamamoto, Janet. (2012). Method for inducing cross-reactive immune responses to the human immunodeficiency virus (hiv) in a host by administering feline immunodeficiency virus (fiv) capsid (ca) or reverse transcriptase (rt) immunogens (U.S. Patent No. 8182820). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8182820

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…